The Women’s Health Products Working Group (WHPWG) was established in 2022 as a commitment under the Action Plan for Medical Devices. The WHPWG brings together the TGA (as Australia’s regulator of therapeutic goods), health professionals, academics and patient groups as a collaborative, advisory forum.
The WHPWG discusses the regulation of health products as they relate to women’s health and examines questions relating to the clinical evidence and policy that support the safety, quality and efficacy of these health products and women’s health. The WHPWG provides advice to the Minister for Health and Aged Care and the TGA, as required. The considerations and outcomes from the WHPWG contribute to the objectives pursued under the National Women’s Health Strategy 2020-2030.
